Site icon Hot Paths

SA Asks: How would Trump’s drug price cuts impact R&D? (XLV:NYSEARCA)

May 17, 2025 1:00 PM ETThe Health Care Select Sector SPDR® Fund ETF (XLV), XBI, IBBAMZN, AMGN, GILD, VRTX, JNJ, GSK, NVS, BMY, RHHBY, PFE, NVO, LLY, MRK, TEVA, AZN, ABBVBy: Val Brickates Kennedy, SA News Editor
Young attractive female scientist holding a red transparent pill

scanrail/iStock via Getty Images

How would President Trump’s proposed price cuts for prescription medications sold in the United States impact the development of new drugs?

We asked Seeking Alpha analysts Stephen Ayers and Edmund Ingham for their views.

Stephen Ayers: If drug prices are subject

Exit mobile version